STUDIES ON THE ROLE OF CYCLIC AMP IN PLATELET FUNCTION*
*
These investigations were supported, in part, by grants AM‐14240 and HE‐03509 from the National Institutes of Health.
Citing Literature
Number of times cited: 37
- Marian A. Packham and Margaret L. Rand, Historical perspective on ADP-induced platelet activation, Purinergic Signalling, 7, 3, (283), (2011).
- Fu-Chao Liu, Chang-Hui Liao, Yao-Wen Chang, Jiin-Tarng Liou and Yuan-Ji Day, Splitomicin suppresses human platelet aggregation via inhibition of cyclic AMP phosphodiesterase and intracellular Ca++ release, Thrombosis Research, 124, 2, (199), (2009).
- Fu-Chao Liu, Chang-Hui Liao, Yao-Wen Chang, Jiin-Tarng Liou and Yuan-Ji Day, A new insight of anti-platelet effects of sirtinol in platelets aggregation via cyclic AMP phosphodiesterase, Biochemical Pharmacology, 77, 8, (1364), (2009).
- Richard J. Haslam, Roles of Cyclic Nucleotides in Platelet Function, Ciba Foundation Symposium 35 ‐ Biochemistry and Pharmacology of Platelets, (121-151), (2008).
- Mirko Magnone, Giovanna Basile, Debora Bruzzese, Lucrezia Guida, Maria Grazia Signorello, Madhu Parakkottil Chothi, Santina Bruzzone, Enrico Millo, Ai-Dong Qi, Robert A. Nicholas, Matthias U. Kassack, Giuliana Leoncini and Elena Zocchi, Adenylic Dinucleotides Produced by CD38 Are Negative Endogenous Modulators of Platelet Aggregation, Journal of Biological Chemistry, 283, 36, (24460), (2008).
- Jörg Geiger, Inhibitors of platelet signal transduction as anti-aggregatory drugs, Expert Opinion on Investigational Drugs, 10, 5, (865), (2001).
- S. Vinaya Kumar and Shelley Bhattacharya, In VitroToxicity of Mercury, Cadmium, and Arsenic to Platelet Aggregation: Influence of Adenylate Cyclase and Phosphodiesterase Activity, In Vitro & Molecular Toxicology, 13, 2, (137), (2000).
- Jörg Geiger, Petra Hönig-Liedl, Peter Schanzenbächer and Ulrich Walter, Ligand specificity and ticlopidine effects distinguish three human platelet ADP receptors, European Journal of Pharmacology, 351, 2, (235), (1998).
- David A. Hall and Susanna M.O. Hourani, Effects of suramin on increases in cytosolic calcium and on inhibition of adenylate cyclase induced by adenosine 5′-diphosphate in human platelets, Biochemical Pharmacology, 47, 6, (1013), (1994).
- Christian GACHET, Jean‐Pierre CAZENAVE, Philippe OHLMANN, Gerhard HILF, Thomas WIELAND and Karl H. JAKOBS, ADP receptor‐induced activation of guanine‐nucleotide‐binding proteins in human platelet membranes, European Journal of Biochemistry, 207, 1, (259-263), (2005).
- K. P. Öhman, J. C. H. Yun and H. R. Keiser, Interaction of prostaglandins with adenosine diphosphate induced increase in cytosolic free calcium in human platelets, Scandinavian Journal of Clinical and Laboratory Investigation, 52, 6, (483), (1992).
- H. Stormorken, T. Lyberg, L. Hakvaag and B. Nakstad, Dissociation of the aggregating effect and the inhibitory effect upon cyclic adenosine monophosphate accumulation by adrenaline and adenosine diphosphate in human platelets, Thrombosis Research, 45, 4, (363), (1987).
- EVELYN MEI HUANG and THOMAS C. DETWILER, Stimulus–Response Coupling Mechanisms, Biochemistry of Platelets, 10.1016/B978-0-12-553240-2.50005-1, (1-68), (1986).
- J.P. Rybicki and G.C. Le Breton, Prostaglandin H2 directly lowers human platelet cAMP levels, Thrombosis Research, 30, 5, (407), (1983).
- Donald E. Macfarlane, David C. B. Mills and Prem C. Srivastava, Binding of 2-azidoadenosine [.beta.-32P]diphosphate to the receptor on intact human blood platelets which inhibits adenylate cyclase, Biochemistry, 21, 3, (544), (1982).
- Thomas Michel, Brian B. Hoffman and Robert J. Lefkowitz, Regulation of Adenylate Cyclase by Adrenergic Receptors, Biochemical Actions of Hormones, 10.1016/B978-0-12-452809-3.50007-5, (43-68), (1982).
- Wen-Hui Tsien, Suzanne P. Sass and Herbert Sheppard, The lack of correlation between inhibition of aggregation and cAMP levels with canine platelets, Thrombosis Research, 28, 4, (509), (1982).
- MALCOLM W. GREAVES, From molecules to medicines*, Clinical and Experimental Dermatology, 5, 4, (375-388), (2006).
- Klaus P. Mellwig and Karl H. Jakobs, Inhibition of platelet adenylate cyclase by ADP, Thrombosis Research, 18, 1-2, (7), (1980).
- M.Sandbjerg Hansen and Nils U. Bang, The influence of plasma proteins on human platelet metabolism, Thrombosis Research, 14, 1, (131), (1979).
- Dermot M. F. Cooper and Martin Rodbell, ADP is a potent inhibitor of human platelet plasma membrane adenylate cyclase, Nature, 282, 5738, (517), (1979).
- R.J. Haslam, M.M.L. Davidson, J.V. Desjardins, J.E.B. Fox and J.A. Lynham, Factors Affecting the Formation and Actions of Cyclic AMP in Blood Platelets, Prostaglandins–Immunopharmacology, 10.1016/B978-0-08-023194-5.50014-0, (75-85), (1979).
- Karl H. Jakobs, GTP-DEPENDENT INHIBITION OF PLATELET ADENYLATE CYCLASE BY α-ADRENERGIC AGONISTS, Cyclic Nucleotides and Protein Phosphorylation in Cell Regulation, 10.1016/B978-0-08-023178-5.50006-9, (11-19), (1979).
- Daniel Osborn, The alpha adrenergic receptor mediated increase in guinea-pig liver glycogenolysis, Biochemical Pharmacology, 27, 9, (1315), (1978).
- E.W. Salzman, D.E. MacIntyre, M.L. Steer and J.L. Gordon, Effect of platelet activity of inhibition of adenylate cyclase, Thrombosis Research, 13, 6, (1089), (1978).
- Grace Jordison Boxer, Holm Holmsen, Linda Robkin, Nils U. Bang, Laurence A. Boxer and Robert L. Baehner, Abnormal Platelet Function in Chediak‐Higashi Syndrome, British Journal of Haematology, 35, 4, (521-533), (2008).
- Robert B. Zurier, Jeffrey Doty and Arnold Goldenberg, Cyclic AMP response to prostaglandin E1 in mononuclear cells from peripheral blood and synovial fluid of patients with rheumatoid arthritis, Prostaglandins, 13, 1, (25), (1977).
- José Roba, Martine Claeys and Georges Lambelin, Antiplatelet and antithrombogenic effects of suloctidil, European Journal of Pharmacology, 37, 2, (265), (1976).
- Sáid A. Assaf, Cyclic amp-mediated phosphorylation reactions in the regulation of blood platelet aggregation, International Journal of Biochemistry, 7, 11, (535), (1976).
- Alfred J. Barber, Cyclic nucleotides and platelet aggregation effect of aggregating agents on the activity of cyclic nucleotide-metabolizing enzymes, Biochimica et Biophysica Acta (BBA) - General Subjects, 444, 2, (579), (1976).
- Manfred Steiner, Endogenous phosphorylation of platelet membrane proteins, Archives of Biochemistry and Biophysics, 171, 1, (245), (1975).
- M. M. COHEN, C. V. GREENWAY, I. R. INNES, G. E. LISTER, V. S. MURTHY and G. D. SCOTT, Further observations on mesenteric vasoconstriction, survival and the clotting defect after endotoxin administration, British Journal of Pharmacology, 48, 4, (555-569), (2012).
- L. Weiss, Studies on cellular adhesion in tissue culture, Experimental Cell Research, 81, 1, (57), (1973).
- , Uncertain Role of Camp in Platelet Function, New England Journal of Medicine, 286, 17, (948), (1972).
- Anne-Lise Pichard, Jacques Hanoune and Jean-Claude Kaplan, Human brain and platelet cyclic adenosine 3′,5′-monophosphate phosphodiesterases: Different response to drugs, Biochimica et Biophysica Acta (BBA) - General Subjects, 279, 1, (217), (1972).
- Edwin W. Salzman, Pamela C. Kensler and Linda Levine, CYCLIC 3′,5′-ADENOSINE MONOPHOSPHATE IN HUMAN BLOOD PLATELETS IV. REGULATORY ROLE OF CYCLIC AMP IN PLATELET FUNCTION*, Annals of the New York Academy of Sciences, 201, 1, (61), (1972).
- Leonard J. Czuba, Chapter 8. Antithrombotic Agents, , 10.1016/S0065-7743(08)60803-9, (78-88), (1972).
